Benjamin Reardon and Emmanuel J Favaloro;
Feb 5, 2026, 16:20
Emmanuel J Favaloro: New Study on Biomarkers for Coagulation Disorders
Emmanuel J Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Biomolecules (MDPI):
“Latest publication from the Sydney Centres for Thrombosis and Haemostasis. Again ably led by Ben Reardon. Biomarkers of Coagulation Disorders.”
Title: Biomarkers of Coagulation Disorders—Where to from Here?
Authors: Benjamin Reardon, Leonardo Pasalic, Emmanuel J. Favaloro
Read the Full Article on Biomolecules (MDPI)
Find more posts featuring Emmanuel J Favaloro on Hemostasis Today.
-
Feb 5, 2026, 16:22Muthukumar R: What if One Blood Test Could Tell Doctors Much More Than it Does Today?
-
Feb 5, 2026, 16:18Maxime Dely: Trends in Red Blood Cell Consumption in France
-
Feb 5, 2026, 16:17Shervin Jose: How Herbal Medicine Changed World History
-
Feb 5, 2026, 16:12Ahmed Koriesh: Stroke Primary Prevention – Questions We Hear Every Day
-
Feb 5, 2026, 16:10Tsubasa Tsutsumi: Hepatology x Cardiology – A Dialogue on Aspirin and Diet in MASLD
-
Feb 5, 2026, 15:37Abhishek Kumar։ Antiphospholipid Syndrome Therapies – Innovations and Market Outlook to 2034
-
Feb 5, 2026, 15:27Ashu Jadhav: Minocycline in Acute Ischaemic Stroke – Results From the EMPHASIS Trial
-
Feb 5, 2026, 15:19Martin Haluzík: How LPA Variants May Guide Aspirin Therapy in Primary Prevention of Cardiovascular Disease
-
Feb 5, 2026, 14:48Ahmed Abdalbagi: Aspirin vs Plavix – Updated Clinical and Pharmacological Breakdown